tranexamic acid has been researched along with Mast-Cell Sarcoma in 1 studies
Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.
Mast-Cell Sarcoma: A unifocal malignant tumor that consists of atypical pathological MAST CELLS without systemic involvement. It causes local destructive growth in organs other than in skin or bone marrow.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Teodorczyk-Injeyan, J | 1 |
| Falk, R | 1 |
| Ng, RW | 1 |
| Kellen, JA | 1 |
1 other study available for tranexamic acid and Mast-Cell Sarcoma
| Article | Year |
|---|---|
The effect of tranexamic acid on growth and spread of an experimental tumor model.
Topics: Animals; Cells, Cultured; Cyclohexanecarboxylic Acids; Cytosol; Mast-Cell Sarcoma; Mice; Mice, Inbre | 1983 |